Literature DB >> 30178917

Genome Editing in Mice Using CRISPR/Cas9 Technology.

Bradford Hall1, Andrew Cho1, Advait Limaye1, Kyoungin Cho2, Jaspal Khillan2, Ashok B Kulkarni1,2.   

Abstract

CRISPR/Cas9 technology has revolutionized genome editing in mice, allowing for simple and rapid development of knockouts and knockins. CRISPR relies on small guide RNAs that direct the RNA-guided nuclease Cas9 to a designated genomic site using ∼20 bp of corresponding sequence. Cas9 then creates a double-strand break in the targeted loci that is either patched in an error-prone fashion to produce a frame-shift mutation, a knockout, or is repaired by recombination with donor DNA containing homology arms, a knockin. This protocol covers the techniques needed to rapidly generate knockout and knockin mice with CRISPR via microinjection of Cas9, the guide RNA, and possible donor DNA into the mouse zygote.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  CRISPR; Cas9; knockin mouse; knockout mouse; transgenic mouse

Mesh:

Substances:

Year:  2018        PMID: 30178917     DOI: 10.1002/cpcb.57

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  10 in total

1.  Single-tube genotyping for small insertion/deletion mutations: simultaneous identification of wild type, mutant and heterozygous alleles.

Authors:  Bin Lin; Jing Sun; Iain D C Fraser
Journal:  Biol Methods Protoc       Date:  2020-03-28

2.  Optimized CRISPR-Cas9-based Strategy for Complex Gene Targeting in Murine Embryonic Stem Cells for Germline Transmission.

Authors:  Thomas J O'Neill; Daniel Krappmann; Andreas Gewies
Journal:  Bio Protoc       Date:  2022-05-20

3.  Spontaneous seizure and memory loss in mice expressing an epileptic encephalopathy variant in the calmodulin-binding domain of Kv7.2.

Authors:  Eung Chang Kim; Jiaren Zhang; Andy Y Tang; Eric C Bolton; Justin S Rhodes; Catherine A Christian-Hinman; Hee Jung Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

Review 4.  Genetically Encoded Tools for Research of Cell Signaling and Metabolism under Brain Hypoxia.

Authors:  Alexander I Kostyuk; Aleksandra D Kokova; Oleg V Podgorny; Ilya V Kelmanson; Elena S Fetisova; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Antioxidants (Basel)       Date:  2020-06-11

Review 5.  Animal models of migraine and experimental techniques used to examine trigeminal sensory processing.

Authors:  Andrea M Harriott; Lauren C Strother; Marta Vila-Pueyo; Philip R Holland
Journal:  J Headache Pain       Date:  2019-08-29       Impact factor: 7.277

6.  Improvement and use of CRISPR/Cas9 to engineer a sperm-marking strain for the invasive fruit pest Drosophila suzukii.

Authors:  Hassan M M Ahmed; Luisa Hildebrand; Ernst A Wimmer
Journal:  BMC Biotechnol       Date:  2019-12-05       Impact factor: 2.563

Review 7.  Knock-In Mouse Models to Investigate the Functions of Opioid Receptors in vivo.

Authors:  Jade Degrandmaison; Samuel Rochon-Haché; Jean-Luc Parent; Louis Gendron
Journal:  Front Cell Neurosci       Date:  2022-01-31       Impact factor: 5.505

8.  Nociceptive signaling through transient receptor potential vanilloid 1 is regulated by Cyclin Dependent Kinase 5-mediated phosphorylation of T407 in vivo.

Authors:  Andrew Cho; Bradford E Hall; Advait S Limaye; Sheng Wang; Man-Kyo Chung; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

9.  Effects of CRISPR/Cas9-mediated stearoyl-Coenzyme A desaturase 1 knockout on mouse embryo development and lipid synthesis.

Authors:  Huibin Tian; Huimin Niu; Jun Luo; Weiwei Yao; Wenchang Gao; Yang Wen; Min Cheng; Anmin Lei; Jinlian Hua
Journal:  PeerJ       Date:  2022-09-14       Impact factor: 3.061

Review 10.  Genetics and functions of the retinoic acid pathway, with special emphasis on the eye.

Authors:  Brian Thompson; Nicholas Katsanis; Nicholas Apostolopoulos; David C Thompson; Daniel W Nebert; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2019-12-03       Impact factor: 4.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.